Medicofarma Biotech SA (WSE:MDB)
Poland flag Poland · Delayed Price · Currency is PLN
0.4930
+0.0250 (5.34%)
At close: Dec 5, 2025

Medicofarma Biotech Company Description

Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.

The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations.

It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests.

The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in February 2021.

Medicofarma Biotech SA was founded in 2001 and is headquartered in Warsaw, Poland. The company operates as a subsidiary of Vitama Spolka Akcyjna.

Medicofarma Biotech SA
Country Poland
Founded 2001
Industry Biotechnology & Medical Research
Sector Healthcare
Employees 20
CEO Cezary Kilczewski

Contact Details

Address:
Sokolowska 9/lok.U19
Warsaw, 01-142
Poland
Phone 48 32 268 6405
Website medicofarmabiotech.pl

Stock Details

Ticker Symbol MDB
Exchange Warsaw Stock Exchange
Fiscal Year January - December
Reporting Currency PLN
SIC Code 8731

Key Executives

Name Position
Cezary Kilczewski Chief Executive Officer